The role of infrapopliteal angioplasty

British Journal of Radiology

Volumn 77, Issue 924, 2004, Pages 1007-1015

  Tsetis, D ^a   Belli, Anna Maria ^a  

^a ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RAPAMYCIN; TACROLIMUS;

ARTERIOGRAPHY; ARTERY LESION; ARTERY OCCLUSION; BALLOON CATHETER; BYPASS SURGERY; CATHETER; CLAUDICATION; CLINICAL TRIAL; COLLATERAL CIRCULATION; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DRUG ELUTING STENT; FEMORAL ARTERY; GERIATRIC PATIENT; GUIDE WIRE; HEALING; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; INTERMETHOD COMPARISON; LASER ANGIOPLASTY; LIFE EXPECTANCY; LIMB BLOOD FLOW; LIMB ISCHEMIA; MEDICAL DECISION MAKING; MEDICAL TECHNOLOGY; MINIMALLY INVASIVE SURGERY; MORBIDITY; MORPHOLOGY; MORTALITY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPLITEAL ARTERY; POSTOPERATIVE COMPLICATION; RECANALIZATION; RESTENOSIS; REVIEW; SALVAGE THERAPY; STENT; SURGICAL INSTRUMENT; SURGICAL RISK; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT PLANNING; ULTRASOUND THERAPY; VASCULAR PATENCY;

ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; CRITICAL ILLNESS; DRUG IMPLANTS; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LASER SURGERY; LEG; LIMB SALVAGE; POPLITEAL ARTERY; STENTS; ULTRASONIC THERAPY;

EID: 11244321802     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/97382129     Document Type: Review

References (103)

1. Dotter CT, Judkins MP. Transluminal treatment of arteriosclerotic obstruction. Description of a new technic and a preliminary report of its application. Circulation 1964;30:654-70.
2. Flueckiger F, Lammer J, Klein GE, Hausegger K, Pilger E, Waltner F, et al. Percutaneous transluminal angioplasty of the crural arteries. Acta Radiologica 1992;33:152-5.
3. Schwarten DE, Cutcliff WB. Arterial occlusive disease below the knee: treatment with percutaneous transluminal angioplasty performed with low-profile catheters and steerable guidewires. Radiology 1988;169:71-4.
4. Bakal CW, Cynamon J, Sprayregen S. Infrapopliteal percutaneous transluminal angioplasty: what we know. Radiology 1996;200:36-43.
5. Pomposelli FB, Marcaccio EJ, Gibbons GW, Campbell DR, Freeman DV, Burgess AM, et al. Dorsalis pedis arterial bypass: durable limb salvage for foot ischemia in patients with diabetes mellitus. J Vasc Surg 1995;21:375-84.
6. Nehler MR, Moneta GL, Edwards JM, Yeager RA, Taylor LMJ, Porter JM. Surgery for chronic lower extremity ischemia in patients eighty or more years of age: operative results and assessment of postoperative independence. J Vasc Surg 1993;18:618-24.
7. Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality: The Whitehall study. Circulation 1990;82:1925-31.
8. Criqui MH, Langer RD, Fronek A, Feigelson HS, Klauber MR, McCann TJ, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992;326:381-6.
9. Newman AB, Sutton-Tyrrell K, Vogt MT, Kuller LH. Morbidity and mortality in hypertensive adults with a low ankle/arm blood pressure index. JAMA 1993;270:487-9.
10. Applegate WB. Ankle/arm blood pressure index: a useful test for clinical practise? JAMA 1993;270:497-8.
11. Isner JM, Rosenfield K. Redefining the treatment of peripheral arterial disease. Role of percutaneous revascularization. Circulation 1993;88:1534-57.
12. The Iloprost bypass international study group. Effects of perioperative Iloprost on patency of femorodistal bypass grafts. Eur J Endovasc Surg 1996;12:363-71.
13. Holm J, Arfvidsson B, Jivegard L, Lundgren F, Lundholm K, Schersten T, et al. Chronic lower limb ischemia: a prospective randomised controlled study comparing the 1-year results of vascular surgery and percutaneous transluminal angioplasty (PTA). Eur J Vasc Surg 1991;5:517-22.
14. Soder HK, Manninen HI, Jaakkola P, Matsi P, Rasanen HT, Kaukanen E, et al. Prospective trial of infrapopliteal artery balloon angioplasty for critical limb ischemia: angiographic and clinical results. J Vasc Interv Radiol 2000;11:1021-31.
15. Norgren L. Definition, incidence and epidemiology. In: Dormandy JA, Stock G, editors. Critical leg ischemia: its pathophysiology and management. Berlin: Springer, 1990: 7-13.
16. The Vascular Surgical Society of Great Britain and Ireland. Critical limb ischemia: management and outcome. Report of a national survey. Eur J Vasc Endovasc Surg 1995;10:108-13.
17. Rutherford RB, Baker D, Ernst C, Johnston KW, Porter JM, Ahn S, et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 1997;26:517-38.
18. Dormandy JA, Thomas PRS. What is the natural history of a critically ischemic patient with and without his leg? In: Greenhalgh RM, Jamieson CW, Nicolaides AN, editors. Limb salvage and amputation for vascular disease. Philadelphia, PA: W.B Saunders, 1998:11-26.
19. Wolfe JHN. Defining the outcome of critical limb ischemia: a one year prospective study. Br J Surg 1986;73:321 (abstract).
20. TASC (2000). Transatlantic Intersociety Consensus (TASC) document on management of peripheral arterial disease. J Vasc Surg 2000;31:S1-S296.
21. Haimovici H. Patterns of arteriosclerotic lesions of the lower extremity. Arch Surg 1967;95:918-33.
22. Fraser SCA, Al-Kutoubi MA, Wolfe JHN. Percutaneous transluminal angioplasty of the infrapopliteal vessels: the evidence. Radiology 1996;200:33-43.
23. Kalra M, Gloviczki P, Bower TC, Panneton JM, Harmsen WS, Jenkins GD, et al. Limb salvage after successful pedal bypass grafting is associated with improved long-term survival. J Vasc Surg 2001;33:6-16.
24. Klevsgard R, Risberg BO, Thomsen MB, et al. A 1-year follow-up quality of life study after hemodynamically successful or unsuccessful surgical revascularization of lower limb ischemia. J Vasc Surg 2001;33:114-22.
25. Gray BH, Laird JR, Ansel GM, Shuck JW. Complex endovascular treatment for critical limb ischemia in poor surgical candidates: a pilot study. J Endovasc Ther 2003;9:599-604.
26. Brodsky JW. Amputations on the foot and ankle. In: Mann RA, Coughlin MJ, editors. Surgery of the foot and ankle (6th edn). St Louis: Mosby Year Book, 1993:959-90.
27. Dorros G, Jaff MR, Murphy KJ, Mathiak L. The acute outcome of tibioperoneal vessel angioplasty in 417 cases with claudication and critical limb ischemia. Cathet Cardiovasc Diagn 1998;45:251-6.
28. Horvath W, Oertl M, Haidinger D. Percutaneous transluminal angioplasty of crural arteries. Radiology 1990;177: 565-9.
29. Bull PG, Mendel H, Hold M, Schlegl A, Denck H, et al. Distal popliteal and tibioperoneal transluminal angioplasty: long-term follow-up. J Vasc Interv Radiol 1992;3:45-53.
30. Grigg MJ, Nicolaides AN, Wolfe JHN. Femorodistal vein bypass graft stenoses. Br J Surg 1988;75:737-40.
31. Mills JL, Fujitani RM, Taylor SM. The characteristics and anatomic distribution of lesions that cause reversed vein graft failure: a five-year prospective study. J Vasc Surg 1993;17:195-206.
32. Darling RC, Linton RR. Durability of femoropopliteal reconstructions. Am J Surg 1972;123:472-9.
33. Gallino A, Mahler F, Probst P, Nachbar B. Percutaneous transluminal angioplasty of the arteries of the lower limbs: a 5 year follow-up. Circulation 1984;70:619-23.
34. Jeans WD, Armstrong S, Cole SEA, Horrocks M, Baird RN. Fate of patients undergoing transluminal angioplasty for lower-limb ischemia. Radiology 1990;177:559-64.
35. Hunink MG, Wong JB, Donaldson MC, Meyerovitz MF, Harrington DP. Patency results of percutaneous and surgical revascularizations for femoropopliteal arterial disease. Med Decision Making 1994;14:71-81.
36. Lammer J, Pilger E, Karnel F, Schurawitzki H, Horvath W, Riedl M, et al. Laser angioplasty. Results of a prospective, multicenter study at 3-year follow-up. Radiology 1991; 178:335-7.
37. Pilger E, Lammer J, Bertuch H, Stark G, Decrinis M, Pfeiffer KP, et al. Nd: YAG laser with sapphire Tipp combined with balloon angioplasty in peripheral arterial occlusions. Long term results. Circulation 1991;83:141-7.
38. Varty K, Bolia A, Naylor AR, Bell PRF, London NJM. Infrapopliteal percutaneous transluminal angioplasty: a safe and successful procedure. Eur J Vasc Endovasc Surg 1995;9:341-5.
39. Schweiger H, Klein P, Lang W. Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: results of primary and secondary procedures. J Vasc Surg 1993;18:867-74.
40. Bolia A, Sayers RD, Thompson MM, Bell PRF. Subintimal and intraluminal recanalization of occluded crural arteries by percutaneous balloon angioplasty. Eur J Vasc Endovasc Surg 1994;8:214-21.
41. Rees MR, Michalis LK. Activated guidewire technique for treating chronic coronary artery occlusion. Lancet 1995; 346:943-4.
42. Tsetis DK, Michalis LK, Rees MR, Katsamouris AN, Matsagas MI, Katsouras CS, et al. Vibrational angioplasty in the treatment of chronic infrapopliteal arterial occlusions: preliminary experience. J Endovasc Ther 2002;9:889-95.
43. Katsouras CS, Michalis LK, Malamou-Mitsi VD, Niokou D, Giogiakas V, Nikas D, et al. Histologic comparison of vibrating guidewire with conventional guidewire technique in an experimental coronary in vivo model. Cardiovasc Intervent Radiol 2003;26:454-8.
44. Herbert JM, Dol F, Bernat A, Falotico R, Lale A, Savi P. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost 1998;80:512-8.
45. Leon MN, Baim DS, Popma JJ, Gordon PC, Cutlip DE, Ho KK, et al. A clinical trial comparing three antithrombotic-drug regimens after coronary-artery stenting: Stent Anticoagulation Restenosis Study Investigators. N Engl J Med 1998;339:1665-75.
46. Rupprecht HJ, Darius H, Borkowski U, Voigtlander T, Nowak B, Genth S, et al. Comparison of antiplatelet effects of aspirin, ticlopidine, or their combination after stent implantation. Circulation 1998;97:1046-52.
47. Moussa I, Oetgen M, Roubin G, Colombo A, Wang X, Iyer S, et al. Effectiveness of clopidogrel and aspirin versus ticlopidin and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999;99:2364-6.
48. Saab MH, Smith DC, Aka PK, Brownlee RW, Killeen JD. Percutaneous transluminal angioplasty of tibial arteries for limb salvage. Cardiovasc Intervent Radiol 1992;15:211-6.
49. Brown KT, Moore ED, Getrajdman GI, Saddekni S. Infrapopliteal angioplasty: long-term follow-up. J Vasc Interv Radiol 1993;4:139-44.
50. Buckenham TM, Loh A, Dormandy JA, Taylor RS. Infrapopliteal angioplasty for limb salvage. Eur J Vasc Surg 1993;7:21-5.
51. Matsi P, Manninen HI, Suhonen MT, Piriren AE, Soimakallio S. Chronic critical lower-limb ischemia: prospective trial of angioplasty with 1-36 months follow-up. Radiology 1993;188:381-7.
52. Sivanathan UM, Browne TF, Thorley PJ, Rees MR. Percutaneous transluminal angioplasty of the tibial arteries. Br J Surg 1994;81:1282-5.
53. Lofberg AM, Lorelius LE, Karacagil S, Westman B, Almgren B, Berqgvist D. The use of below-knee percutaneous transluminal angioplasty in arterial occlusive disease causing chronic critical limb ischemia. Cardiovasc Intervent Radiol 1996;19:317-22.
54. Dorros G, Jaff MR, Dorros AM, Mathiak LM, Thomas RN, He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five year follow-up. Circulation 2001;104:2057-62.
55. Jamsen T, Manninen H, Tulla H, Matsi P. The final outcome of primary infrainguinal percutaneous transluminal angioplasty in 100 consecutive patients with chronic critical limb ischemia. J Vasc Interv Radiol 2002;13:455-63.
56. Ingle H, Nasim A, Bolia A, Fishwick G, Naylor R, Bell PRF, et al. Subintimal angioplasty of isolated infragenicular vessels in lower limb ischemia: long-term results. J Endovasc Ther 2002;9:411-6.
57. Boyer L, Therre T, Garcier JM, Perez N, Ravel A, Privat C, et al. Infrapopliteal percutaneous transluminal angioplasty for limb salvage. Acta Radiol 2000;41:73-7.
58. Parsons RE, Suggs WD, Lee JJ, Sanchez LA, Lyon RT, Veith FJ. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg 1998; 28:1066-71.
59. London NJ, Varty K, Sayers RD, Thompson MM, Bell PR, Bolia A. Percutaneous transluminal angioplasty for lower-limb critical ischaemia. Br J Surg 1995;82: 1232-5.
60. Vraux H, Hammer F, Verhelst R, Goffette P, Vandeleene B. Subintimal angioplasty of tibial vessel occlusions in the treatment of critical limb ischemia: mid-term results. Eur J Vasc Endovasc Sing 2000;20:441-6.
61. Varty K, Nydahl S, Butterworth P, Errington M, Bolia A, Bell PRF, et al. Changes in the management of critical limb ischemia. Br J Surg 1996;83:953-6.
62. Reekers JA. Percutaneous intentional extralumial (subintimal) revascularization (PIER) for critical lower limb ischemia: too good to be true? J Endovasc Ther 2002; 9:419-21.
63. Ballard JL, Killeen JD, Smith LL. Popliteal-tibial bypass grafts in the management of life-threatening ischemia. Arch Surg 1993;128:976-80.
64. Effects of perioperative iloprost on patency of femorodistal bypass grafts. The Iloprost Bypass International Study Group. Eur J Vasc Endovasc Surg 1996;12:363-71.
65. Biancari F, Kantonen I, Alback A, Ihlberg L, Lehtola A, Lepantalo M, et al. Popliteal-to-distal bypass grafts for critical leg ischemia. J Cardiovasc Surg (Torino) 2000;41:281-6.
66. Quinones-Baldrich WJ, Colburn MD, Ahn SS, Gelabert HA, Moore WS. Very distal bypass for salvage of the severely ischemic extremity. Am J Surg 1993;166:117-23.
67. Gloviczki P, Bower TC, Toomey BJ, Mendoca C, Naessens JM, Schabauer AM, et al. Microscope-aided pedal bypass is an effective and low-risk operation to salvage the ischemic foot (review). Am J Surg 1994;168: 76-84.
68. Rhodes JM, Gloviczki P, Bower TC, Panneton JM, Canton LG, Toomey BJ. The benefits of secondary interventions in patients with failing or failed pedal bypass grafts. Am J Surg 1999;178:151-5.
69. Watson HR, Schroeder TV, Simms MH, Buth J, Horrocks M, Norgren L, et al for the Iloprost Bypass International Study Group. Relationship of femorodistal bypass patency to clinical outcome. Eur J Vasc Endovasc Surg 1999;17:77-83.
70. Nicoloff AD, Taylor LMJ, McLafferty RB, Moneta GL, Porter JM. Patient recovery after infrainguinal bypass grafting for limb salvage. J Vasc Surg 1998;27:256-66.
71. Brillu C, Piquet J, Villapadierna F, Papon X, L'Hoste P, Jousset Y, et al. Percutaneous transluminal angioplasty for management of critical ischemia in arteries below the knee. Ann Vasc Surg 2001;15:175-81.
72. Vainio E, Salenius JP, Lepantalo M, Luther M, Ylonen K. Endovascular surgery for chronic lower limb ischemia. Factors predicting immediate outcome on the basis of a nationwide vascular registry. Ann Chir Gynaecol 2001;90:86-91.
73. Cutteridge W, Torrie EP, Galland RB. Cumulative risk of bypass, amputation or death following percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg 1997;14: 134-9.
74. Danielsson G, Albrechtsson U, Norgren L, Danielsson P, Ribbe E, Thorne J, et al. Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing outcome. Eur J Vasc Endovasc Surg 2001; 21:432-6.
75. Mlekusch W, Schillinger M, Sabeti S, Maca T, Ahmadi R, Minar E. Clinical outcome and prognostic factors for ischaemic ulcers treated with PTA in lower limbs. Eur J Vasc Endovasc Surg 2002;24:176-81.
76. Marzelle J, Raffoul R, Mekouar T, Laridon D, Cormier F, Fichelle JM, et al. Long-term outcome of infra-inguinal endovascular surgery for critical ischemia. Chirurgie 1998;123:162-7.
77. Parsons RE, Suggs WD, Lee JJ, Sanchez LA, Lyon RT, Veith FJ. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting? J Vasc Surg 1998; 28:1066-71.
78. Treiman GS, Treiman RL, Ichikawa L, Van Allan R. Should percutaneous transluminal angioplasty be recommended for treatment of infragenicular popliteal artery or tibioperoneal trunk stenosis? J Vasc Surg 1995;22: 457-65.
79. Bakal CW, Sprayregen S, Scheinbaum K, Cynamon J, Veith FJ. Percutaneous transluminal angioplasty of the infrapopliteal arteries: results in 53 patients. AJR Am J Roentgenol 1990;154:171-4.
80. Karacagil S, Almgreen B, Bowald S, Eriksson I. Arterial lesions of the foot vessels in diabetic and non-diabetic patients undergoing lower limb revascularisation. Eur J Vasc Surg 1989;3:239-44.
81. Heintzen MP, Strauer BE. Peripheral arterial complications after heart catheterzation. Herz 1998;23:4-20.
82. Duda SH, Wikirchen J, Erb M, Schott UG, Khaligi K, Pereira PL, et al. Closure antegrade femoral artery access sites in patients who have received full anticoagulation therapy. Radiology 1999;21:47-52.
83. Michalis LK, Rees MR, Patsouras D, Katsouras CS, Goudevenos J, Pappas S, et al. A prospective randomised trial comparing the safety and efficacy of three commercially available closure devices (angioseal, vasoseal and duett). Cardiovasc Intervent Radiol 2002;25:423-9.
84. Hayes PD, Chokkalingam A, Jones R, Bell PR, Fishwick G, Bolia A, et al. Arterial perforation during infrainguinal lower limb angioplasty does not worsen outcome: results from 1409 patients. J Endovasc Ther 2002;9:422-7.
85. Belli AM, Cumberland DC, Knox AM, Procter AE, Welsh CL. The complication rate of percutaneous peripheral balloon angioplasty. Clin Radiol 1990;41:380-3.
86. Wengerter KR, Veith FJ, Gupta SK, Goldsmith J, Farrell E, Harris PL, et al. Prospective randomized multicenter comparison of in situ and reversed vein infrapopliteal bypasses. J Vasc Surg 1991;13:189-99.
87. Das TS. Percutaneous peripheral revascularisation with excimer laser: equipment, technique and results. Lasers Med Sci 2001;16:101-7.
88. Oraevsky AA, Jacques SL, Pettit GH, Saidi IS, Tittel FK, Henry PD. XeCI laser ablation of atherosclerotic aorta: optical properties and energy pathways. Lasers Surg Med 1992;12:585-97.
89. Taylor RS, Higginson AJ, Leopold KE. Dependence of the XeCI laser cut rate of plaque on the degree of calcification, laser fluence, and optical pulse duration. Lasers Surg Med 1990;10:414-9.
90. Bittl JA. Clinical results with excimer laser coronary angioplasty. Semin Interv Cardiol 1996;1:129-34.
91. Laird JR, Reiser C, Biamino G, Zeller T. Excimer laser assisted angioplasty for the treatment of critical limb ischemia. J Cardiovasc Surg 2004;45:239-48.
92. Barath P, Fishbein MC, Vari S, Forrester JS. Cutting balloon: a novel approach to percutaneous angioplasty. Am J Cardiol 1991;68:1249-52.
93. Barath P. Microsurgical dilatation concept: animal data. J Invasive Cardiol 1996; 8 (Suppl. A);2A-5A.
94. Engelke C, Morgan RA, Belli AM. Cutting balloon percutaneous transluminal angioplasty for salvage of lower limb arterial bypass grafts: feasibility. Radiology 2002;223:106-14.
95. Ansel GM, Sample NS, Botti CF, Tracy AJ, Silver MJ, Marshall BJ, et al. Cutting balloon angioplasty of the popliteal infrapopliteal vessels for symptomatic limb ischemia. Catheter Cardiovasc Interv 2004;61:1-4.
96. Fitzgerald PJ, Takagi A, Moore MP, Hayase M, Kolodgie FD, Corl D, et al. Intravascular sonotherapy decreases neointimal hyperplasia after stent implantation in swine. Circulation 2001;103:1828-31.
97. Mudra H, Hug M, Knape A, Spes C. Intravascular sonotherapy for treatment of in-stent restenosis. Z Kardiol 2002;91 Suppl. 3:103-7.
98. Kataoka T, Honda Y, Bonneau HN, Yock PG, Fitzgerald PJ. New catheter-based technology for the treatment of restenosis. J Interv Cardiol 2002;15:371-9.
99. Rand T, Funovics M, Schoder M, Kettenbach J, Cejna M, Lammer J, et al. Stent versus PTA for the treatment of infrapopliteal lesions. Work in progress. Cardiovasc Intervent Radiol 2002;25 (Suppl. 2):S247.
100. Duda SH, Poerner TC, Wiesinger B, Rundback JH, Tepe G, Wiskirchen J, et al. Drug-eluting stents: potential applications for peripheral arterial occlusive disease. J Vasc Interv Radiol 2003;14:291-301.
101. Duda SH, Wiesinger B, Richter GM, Landwehr P, Oliva V, Tielbeek A, et al. Sirolimus-eluting stents in SFA obstructions: long-term SIROCCO trial results. CIRSE 2003 Annual Meeting and Postgraduate Course. Main Programme and Abstracts: abstr 35.3.2, p 157.
102. Heublein B, Rhode R, Kaese V, Niemeyer M, Hartung W, Haverich A. Biocorrosion of magnesium alloys: a new principle in cardiovascular implant technology. Heart 2003;89:651-6.
103. Tsuji T, Tamai H, Igaki K, Kyo E, Kosuga K, Hata T, et al. Biodegradable stents as a platform to drug loading. Int J Cardiovasc Intervent 2003;5:13-6.